These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25561185)

  • 1. Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers.
    Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Yamamoto T; Addeo P; Jaeck D; Bachellier P
    World J Surg; 2015 May; 39(5):1167-76. PubMed ID: 25561185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.
    Oussoultzoglou E; Bachellier P; Rosso E; Scurtu R; Lucescu I; Greget M; Jaeck D
    Ann Surg; 2006 Jul; 244(1):71-9. PubMed ID: 16794391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.
    Yamamoto S; Tanaka K; Takeda K; Akiyama H; Ichikawa Y; Nagashima Y; Endo I
    Ann Surg Oncol; 2014 Jun; 21(6):1853-61. PubMed ID: 24554065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential clinical benefits of 5-fluorouracil-based adjuvant chemotherapy for patients with stage III colorectal cancer according to CD133 expression status.
    Shikina A; Shinto E; Hashiguchi Y; Ueno H; Naito Y; Okamoto K; Kubo T; Fukazawa S; Yamamoto J; Hase K
    Jpn J Clin Oncol; 2014 Jan; 44(1):42-8. PubMed ID: 24244031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
    Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
    Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of biomarkers expression before and after portal vein embolization on recurrence after two-stage hepatectomy for colorectal liver metastases.
    Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rosso E; Pessaux P; Jaeck D; Bachellier P
    J Gastrointest Surg; 2012 Mar; 16(3):554-61. PubMed ID: 22125166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
    Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
    Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.
    Lee AJ; Loyer EM; Kang HC; Aloia TA; Tzeng CD; Vauthey JN; Chun YS
    Ann Surg Oncol; 2019 Jan; 26(1):275-281. PubMed ID: 30362064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
    Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
    HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for multiple bilobar liver metastases of colorectal cancer.
    Shimada H; Tanaka K; Matsuo K; Togo S
    Langenbecks Arch Surg; 2006 Apr; 391(2):130-42. PubMed ID: 16320065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal liver metastases: hepatic pedicle clamping during hepatectomy reduces the incidence of tumor recurrence in selected patients. Case-matched analysis.
    De Carlis L; Di Sandro S; Giacomoni A; Mihaylov P; Lauterio A; Mangoni I; Cusumano C; Poli C; Tripepi M; Bencardino K
    Eur J Surg Oncol; 2013 Jul; 39(7):726-33. PubMed ID: 23601983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases.
    Lam VW; Laurence JM; Pang T; Johnston E; Hollands MJ; Pleass HC; Richardson AJ
    HPB (Oxford); 2014 Feb; 16(2):101-8. PubMed ID: 23509899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.